We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Blacktrace Launches Dolomite Bio
News

Blacktrace Launches Dolomite Bio

Blacktrace Launches Dolomite Bio
News

Blacktrace Launches Dolomite Bio

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Blacktrace Launches Dolomite Bio"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

rsz_rna_seq_with_a_bead_85um.jpg

Blacktrace Holdings Limited is pleased to announce the launch of its latest brand, Dolomite Bio. This biology-focused brand – spun out from sister company Dolomite Microfluidics – is dedicated to the development of innovative products for high throughput single cell research. 

Dolomite Bio specializes in microfluidic droplet applications, offering a range of microfluidic systems and individual modules, as well as control software and reagents, for cell biology applications. Its core droplet technology is fully scalable, enabling microdroplet encapsulation of individual cells and molecules – from a few cells to millions or more – in just a few minutes. It is ideal for a wide variety of high throughput, single cell research applications, including:

•           Single cell RNA-Seq

•           Direct isolation of functional antibody coding sequence libraries

•           Profiling natively-paired T-cell receptors

•           Directed evolution by FACS sorting 

•           Functional antibody screening in droplets

•           Cell encapsulation in hydrogels

Mike Hawes, CEO of Dolomite Bio, said: “We are delighted to announce the launch of Dolomite Bio, which will focus on developing novel products for high throughput single cell research. This new brand takes advantage of Dolomite Microfluidics’ underlying technology and the Blacktrace group’s understanding of the market to serve customers in this rapidly growing field.”

Advertisement